Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 4/20 | 0.69 |
| ▸ | HRH1 | P35367 | 4/20 | 0.69 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.53 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.53 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.51 |
| ▸ | SCN1A | P35498 | 2/20 | 0.51 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.51 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.50 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19121804 | 1.00 | HTR2A (0.69) | HTR2AHRH1AOC3RIPK1CHRM2 | |
| SCHEMBL22515947 | 1.00 | HTR2A (0.69) | HTR2AHRH1AOC3RIPK1CHRM2 | |
| SCHEMBL11488300 | 0.88 | HTR2A (0.55) | HTR2AHRH1 | |
| SCHEMBL11566877 | 0.88 | HTR2A (0.71) | HTR2AHRH1AOC3RIPK1CHRM2 | |
| SCHEMBL17451533 | 0.84 | RIPK1 (0.55) | HTR2AHRH1AOC3RIPK1TAAR1 | |
| SCHEMBL11379245 | 0.84 | HTR2A (0.50) | HTR2AHRH1AOC3RIPK1CHRM2 | |
| SCHEMBL11486794 | 0.84 | LTA4H (0.56) | HTR2AHRH1 | |
| SCHEMBL1802493 | 0.82 | HRH1 (1.00) | HTR2AHRH1CHRM2SLC6A2SLC6A4 | |
| SCHEMBL14064905 | 0.82 | AOC3 (0.48) | HTR2AHRH1AOC3RIPK1TAAR1 | |
| SCHEMBL6280516 | 0.81 | RIPK1 (0.67) | AOC3RIPK1CHRM2SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1187244-A2 | Organic amines as additives for electrochemical cells | MERCK PATENT GmbH (DE) | 2002-03-13 | — | — | EP | claimed |
| US-20230357249-A1 | ANDROGEN RECEPTOR PROTEIN DEGRADERS WITH A TRICYCLIC CEREBLON LIGAND | UNIV MICHIGAN REGENTS (US) | 2023-11-09 | — | — | US | disclosed |
| US-20230357249-A1 | ANDROGEN RECEPTOR PROTEIN DEGRADERS WITH A TRICYCLIC CEREBLON LIGAND | UNIV MICHIGAN REGENTS (US) | 2023-11-09 | — | — | US | disclosed |
| US-20170266167-A1 | ERK INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2017-09-21 | — | — | US | disclosed |
| US-8883828-B2 | 2-aminopyridine analogs as glucokinase activators | ARRAY BIOPHARMA INC. (US) | 2014-11-11 | — | — | US | disclosed |
| US-20100323098-A1 | ELECTRODE MATERIAL FOR RECHARGEABLE LITHIUM BATTERY, ELECTRODE STRUCTURAL BODY COMPRISING SAID ELECTRODE MATERIAL, RECHARGEABLE LITHIUM BATTERY HAVING SAID ELECTRODE STRUCTURAL BODY, PROCESS FOR THE PRODUCTION OF SAID ELECTRODE STRUCTURAL BODY, AND PROCESS FOR THE PRODUCTION OF SAID RECHARGEABLE LITHIUM BATTERY | CANON KABUSHIKI KAISHA (JP) | 2010-12-23 | — | — | US | disclosed |
| US-7803290-B2 | Electrode material for rechargeable lithium battery, electrode structural body comprising said electrode material, rechargeable lithium battery having said electrode structural body, process for the production of said electrode structural body, and process for the production of said rechargeable lithium battery | CANON KABUSHIKI KAISHA (JP) | 2010-09-28 | — | — | US | disclosed |
| WO-2008062473-A1 | PROCESS FOR PREPARING ATOMOXETINE HYDROCHLORIDE | CADILA HEALTHCARE LIMITED (IN) | 2008-05-29 | — | — | WO | disclosed |
| US-20080090152-A1 | Electrode material for rechargeable lithium battery, electrode structural body comprising said electrode material, rechargeable lithium battery having said electrode structural body, process for the production of said electrode structual body, and process for the production of said rechargeable lithium battery | CANON KABUSHIKI KAISHA (JP) | 2008-04-17 | — | — | US | disclosed |
| US-7316792-B2 | Electrode material for rechargeable lithium battery and electrode structural body comprising said electrode material | CANON KABUSHIKI KAISHA (JP) | 2008-01-08 | — | — | US | disclosed |
| US-7141187-B2 | Electrode material for rechargeable lithium battery, electrode structural body comprising said electrode material, rechargeable lithium battery having said electrode structural body, process for the production of said electrode structural body, and process for the production of said rechargeable lithium battery | CANON KABUSHIKI KAISHA (JP) | 2006-11-28 | — | — | US | disclosed |
| US-20060237697-A1 | Electrode material for rechargeable lithium battery, electrode structural body comprising said electrode material, rechargeable lithium battery having said electrode structural body, process for the production of said electrode structural body, and process for the production of said rechargeable lithium battery | CANON KABUSHIKI KAISHA (JP) | 2006-10-26 | — | — | US | disclosed |
| US-20030157407-A1 | Electrode material for rechargeable lithium battery, electrode structural body comprising said electrode material, rechargeable lithium battery having said electrode structural body, process for the production of said electrode structural body, and process for the production of said rechargeable lithium battery | CANON KABUSHIKI KAISHA (JP) | 2003-08-21 | — | — | US | disclosed |
| EP-1313158-A2 | Electrode material for rechargeable lithium battery, electrode comprising said electrode material, rechargeable lithium battery having said electrode , and process for the production thereof | CANON KABUSHIKI KAISHA (JP) | 2003-05-21 | — | — | EP | disclosed |
| EP-1187244-A2 | Organic amines as additives for electrochemical cells | MERCK PATENT GmbH (DE) | 2002-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357249-A1 | ANDROGEN RECEPTOR PROTEIN DEGRADERS WITH A TRICYCLIC CEREBLON LIGAND | AR, GPER1, CRBN | HTR2A 264/4885HRH1 2651/4885AOC3 997/4885 |
| US-20170266167-A1 | ERK INHIBITORS | MAPK1, MAPK3, MAPK6 | HTR2A 4554/4885HRH1 1861/4885AOC3 4513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.